0 items USD 0.00Search
Your search for "DLBCL" gave back 31 results.
Highlights The global Hematological Malignancy Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
颁补迟补濒辞驳:听
MRRPB5
January 2023
Price: USD 2,900.00
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2018 Summary...
颁补迟补濒辞驳:听
Global Markets Direct
January 2018
Price: USD 3,500.00
The global Hematological Malignancy Treatment market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by...
颁补迟补濒辞驳:听
GIR
March 2025
Price: USD 3,480.00
The global Hematological Malignancy Treatment market size was valued at US$ million in 2023. With growing demand in downstream market, the...
颁补迟补濒辞驳:听
LPI
October 2024
Price: USD 3,660.00
The global Hematological Malignancy Drugs market size was valued at US$ million in 2023. With growing demand in downstream market, the Hematological...
颁补迟补濒辞驳:听
LPI
July 2024
Price: USD 3,660.00
The global Hematological Malignancy Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
颁补迟补濒辞驳:听
GIR
November 2024
Price: USD 3,480.00
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H1 2019 Summary...
颁补迟补濒辞驳:听
Global Markets Direct
March 2019
Price: USD 3,500.00
Baculoviral IAP Repeat Containing Protein 5 (Apoptosis Inhibitor 4 or Apoptosis Inhibitor Survivin or BIRC5) - Pipeline Review, H2 2018 Summary...
颁补迟补濒辞驳:听
Global Markets Direct
July 2018
Price: USD 3,500.00
The global CAR T-Cell Therapy market size is predicted to grow from US$ 6539 million in 2025 to US$ 27400 million in 2031; it is expected to grow at...
颁补迟补濒辞驳:听
LPI
April 2025
Price: USD 3,660.00
The global market for CAR T-Cell Therapy was valued at US$ 5417 million in the year 2024 and is projected to reach a revised size of US$ 26750...
颁补迟补濒辞驳:听
MRRPB5
March 2025
Price: USD 2,900.00
The global market for CAR T-Cell Therapy was valued at US$ 4087 million in the year 2023 and is projected to reach a revised size of US$ 21680...
颁补迟补濒辞驳:听
MRRPB5
January 2025
Price: USD 2,900.00
The global CAR T-Cell Therapy market size is predicted to grow from US$ 5299 million in 2024 to US$ 22200 million in 2030; it is expected to grow at...
颁补迟补濒辞驳:听
LPI
March 2025
Price: USD 3,660.00
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9...
颁补迟补濒辞驳:听
Global Markets Direct
April 2018
Price: USD 3,500.00
Tumor Necrosis Factor Receptor Superfamily Member 9 (4-1BB Ligand Receptor or T Cell Antigen 4-1BB Homolog or T Cell Antigen ILA or CD137 or TNFRSF9...
颁补迟补濒辞驳:听
Global Markets Direct
October 2018
Price: USD 3,500.00
The global CAR T-Cell Therapy market size was valued at US$ 4205 million in 2024 and is forecast to a readjusted size of USD 21660 million by 2031...
颁补迟补濒辞驳:听
GIR
January 2025
Price: USD 3,480.00
听
